Top Markets
Coin of the day
Evaxion Biotech A/S Evaxion Biotech A/S

Evaxion Biotech A/S

EVAX
Rangering i aksjer #29742
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to... Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.
Aksjekurs
$3.15
Sist synkronisert: 2026-08-18
Markedsverdi
$19.90M
Endring (1 dag)
0.64%
Endring (1 år)
3.62%
Land
DK
Handel Evaxion Biotech A/S (EVAX)

Kategori

Historikk for aksjesplitt for Evaxion Biotech A/S (EVAX)
Aksjen Evaxion Biotech A/S (symbol: EVAX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 19, 2026.
Én EVAX-aksje kjøpt før Aug 19, 2026 tilsvarer i dag 0 EVAX-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH